Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akcea therapeutics
boston blog main
boston top stories
clinical trials
inotersen
life sciences
national blog main
national top stories
new york blog main
new york top stories
onpattro
patisiran
2
×
pfizer
san diego blog main
san diego top stories
tafamidis
alnylam pharmaceuticals
andrew fire
anylam pharmaceuticals
boston
cardiomyopathy
craig mello
drugs
fda
hereditary transthyretin amyloidosis
john maraganore
neuropathy
new york
nobel prize
rna interference
san francisco blog main
san francisco top stories
tegsedi
transthyretin amyloidosis
vyndaqel
What
alnylam
approved
2
×
drug
fda
2
×
afternoon
ago
akcea
alnylam’s
amyloidosis
attr
available
battle
debilitating
disease
genetic
gets
history
landmark
making
medicine
medicines
ok
oks
onpattro
patients
patisiran
pfizer
pharmaceuticals
rare
rnai
sets
specifically
transthyretin
year
Language
Current search:
patisiran
×
approved
×
fda
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug